Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy

• TOMITA Akihiro

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• HIRAGA Junji

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• KIYOI Hitoshi

  Department of Infectious Diseases, Nagoya University School of Medicine

• NINOMIYA Manabu

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• SUGIMOTO Takumi

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• ITO Masafumi

  Department of Pathology, Japanese Red Cross Nagoya First Hospital

• KINOSHITA Tomohiro

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• NAOE Tomoki

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

Journal

• Int J Hematol.

  Int J Hematol. 86 (1), 49-57, 2007-01-15

Keywords

• CD20
• Rituximab
• B-cell lymphoma
• Epigenetics

Details

• CRID: 1570009750438846848
• NII Article ID: 10018515585
• NII Book ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2007217584
• Text Lang: en
• Data Source:
  • CiNii Articles